{"name":"PeproMene Bio, Inc.","slug":"pepromene-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BAFFR-CAR T cells","genericName":"BAFFR-CAR T cells","slug":"baffr-car-t-cells","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"BAFFR-CAR T cells","genericName":"BAFFR-CAR T cells","slug":"baffr-car-t-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2025-05-20","type":"pipeline","source":"PR Newswire","summary":"PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Comp","headline":"PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPelJIQ1ZxanpFR2tqYnlQX0x3Nkp4Z2xUcU1WclU1ZGo2X0k3OXcwcGM3ZGZ4VHNQQV9WTUxFTHg3N3dPR0pQdktOTk5MSzQ2MnZjTGVvTFh2c1FZU0oyWVNYXzRta19DT3c2eFFfNlRGUzhRelhPQVd0MS1kT0tfTVVHSG4?oc=5","date":"2025-02-17","type":"pipeline","source":"Los Angeles Business Journal","summary":"City of Hope Is Leader in Field - Los Angeles Business Journal","headline":"City of Hope Is Leader in Field","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOdG5HU0kwZUNwSWpYcl8wQmNEMGg1a2gya0lRN1c5SDFfWDUtZzU0ZTdtUEw2TXI2YzRpMG91NHJuYW9rZF9TUldVaHR1MU5GUkdndDF2THo1SHhna1RXXzJ1UVN2VWdqX1kxeU52dmlQeGJrd3QwZmktV3NYa3pzcjVBSTMtNGNPZU9YdHZyUXJnaFYxdlFtRElHazdzem5KMVZwY3F1WkRCMEd5eTE2b2NFNXZTMHhPT2dzc2pkLVNaYTBEdnF2OFJVbXpGM0d2eDVwSXhYMUxXcVEtT2IzaG9aYWZHLXkz?oc=5","date":"2025-01-06","type":"regulatory","source":"CRISPR Medicine News","summary":"Press Release Service: CAR-T Cell Therapy Market Research 2024-2025: Size, Forecasts, Trials, and Trends - Approved CAR-T Therapies and Late-stage Clinical Trials that Could Reach Commercialization So","headline":"Press Release Service: CAR-T Cell Therapy Market Research 2024-2025: Size, Forecasts, Trials, and Trends - Approved CAR-","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxNRGJjcHFjeE1aU0JsYXpndmJualBoUkdJQkVIT28tU3FMYWdYTWR0cTFURndON1Mxd0NCZ1R4clZPTUkwT1h4OXhMeTlzcGg0SjNvanBneW5OcU50UlpyTDNnR1d0WWFqdjBReTVFblZZQ1A0Q3FJT1AtMHZCMmctVl9TbWpua0kwYU1vbkFpNmNlT3NadjhvNThXOW9VbTFfaXU2X2M5SWpBRVdwd2ZCMWFPeTFIQ2VWbFBkVk5fYUx4d01TNEc4RlMtdEVUcTNNcUlCeUxOWEpvbDZhZVE?oc=5","date":"2024-12-20","type":"pipeline","source":"BioPharma APAC","summary":"PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma - BioPharma APAC","headline":"PeproMene Bio Secures $11M Investment to Advance BAFF-R CAR T Therapy for Relapsed Follicular Lymphoma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}